Proteomic analysis of canine vaccines
American Journal of Veterinary Research · 2023
DOI: 10.2460/ajvr.22.11.0192 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2023. Verfasst von Jackeline Franco und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, 47907. Hauptthemen laut MEDLINE: Rabies Vaccines, Rabies, Viral Vaccines, Distemper. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE To use proteomic analysis to identify qualitatively and quantitatively mammalian protein components of commercial veterinary vaccines against canine distemper, leptospirosis, borreliosis, and rabies. SAMPLE 25 licensed veterinary vaccines (from 4 different manufacturers) against canine distemper and leptospirosis, borreliosis, and rabies (3-year and 1-year durations of immunity). PROCEDURES Duplicate samples from a single-lot vial of each vaccine were prepared by acetone precipitation and proteolysis with trypsin and Lys-C protease mix. Peptides mixtures (1 μg) were analyzed by liquid chromatography-tandem mass spectrometry using an Orbitrap Fusion Lumos mass spectrometer. Liquid chromatography-tandem mass spectroscopy data were searched against a Bos taurus protein database using MaxQuant to identify and quantify mammalian proteins in the vaccines. Identified proteins were classified by function and network analysis to visualize interactions. RESULTS The largest number of mammalian proteins was identified in 3-year rabies vaccines (median, 243 proteins; range, 184 to 339 proteins) and 1-year rabies vaccines (median, 193 proteins; range, 169 to 350 proteins). Borrelia and leptospirosis-distemper (L&D) vaccines had the lowest number of proteins. Rabies vaccines had the highest number of identified proteins in common (n = 316); 33 were unique to 1-year products and 44 were found in 3-year products. Borrelia and L&D vaccines had 16 and 22 uniquely identified proteins, respectively. The protein classifications were primarily modulators of protein-binding activity, enzymes, transfer-carrier proteins, cytoskeletal proteins, defense-immunity proteins, calcium-binding proteins, and extracellular matrix proteins. CLINICAL RELEVANCE This study demonstrates proteomics application to evaluate quality differences among different vaccines, identifying potential stimulants of desirable and undesirable immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, 47907.
- Bindley Bioscience Center, Purdue University, West Lafayette, Indiana, 47907.
Zitieren
APA
Franco, J., Aryal, U. K., HogenEsch, H., & Moore, G. E. (2023). Proteomic analysis of canine vaccines. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.22.11.0192
Vancouver
Franco J, Aryal UK, HogenEsch H, Moore GE. Proteomic analysis of canine vaccines. American Journal of Veterinary Research. 2023. doi:10.2460/ajvr.22.11.0192
BibTeX
@article{Franco2023,
author = {Franco, Jackeline and Aryal, Uma K and HogenEsch, Harm and Moore, George E},
title = {Proteomic analysis of canine vaccines},
journal = {American Journal of Veterinary Research},
year = {2023},
doi = {10.2460/ajvr.22.11.0192}
}
EUVIMED